首页 > 市场调查报告书 > 製药

OTC 非处方药

市场调查报告书

商品编码

1529563

戒烟和尼古丁成瘾预防产品市场：按给药途径、按产品、按分销管道、按地区

Smoking Cessation and Nicotine De-addiction Products Market, By Route of Administration, By Product, By Distribution Channel, By Geography

出版日期: 2024年07月18日 | 出版商:

Coherent Market Insights | 英文 358 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年全球戒烟和尼古丁成瘾产品市场价值为165.5亿美元，预计到2031年将达到501亿美元，2024年至2031年的复合年增长率为17.1%。

报告范围		报告详情
基准年	2023年	2024年市场规模	165.5亿美元
实际资料	2019-2023	预测期	2024-2031
2024-2031 年预测期复合年增长率	17.10%	2031 年金额预测	501亿美元

图：戒烟和尼古丁成瘾预防产品的市场占有率（%）（2024年，按地区）

由于世界吸烟人口的增加以及人们对吸烟造成的健康风险的认识不断增强，戒烟和尼古丁成瘾预防产品的全球市场正在经历显着增长。吸烟已成为全球公共卫生问题，世界卫生组织（WHO）建议采取多种措施帮助人们戒烟。尼古丁替代疗法和其他戒烟辅助剂已被证明可以有效帮助吸烟者戒烟。一些政府和非政府组织的宣传宣传活动正在推动对尼古丁口香糖、贴片、含片和戒烟处方药的需求。产品配方和新技术的进步正在扩大想要戒烟的吸烟者的选择。然而，某些戒烟产品的高成本和烟瘾的持续存在给产业带来了挑战。

市场动态：

全球戒烟和尼古丁成瘾预防产品市场的成长是由吸烟相关疾病的日益流行、消费者健康意识的提高以及公共机构遏制烟草使用的各种倡议所推动的。然而，某些戒烟治疗的高成本以及烟草业反对产品监管的强烈游说正在限制市场成长。戒烟治疗数位解决方案的激增正在开闢新的机会。人们已经开发了各种行动应用程式和线上程序，以提高尼古丁替代疗法和消费者行为支援的有效性。尼古丁替代输送形式的创新也是一个受到关注的关键趋势。

本研究的主要特点

本报告对全球戒烟和尼古丁成瘾预防产品市场进行了详细分析，并提出了以2023年为基础的预测期（2024-2031）的市场规模（十亿美元）和年复合成长率（CAGR%）年。 %）发布。
它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
根据公司亮点、产品系列、主要亮点、绩效和策略等参数，提供全球戒烟和尼古丁成瘾预防产品市场主要企业的概况。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
全球戒烟和尼古丁成瘾产品市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过全球戒烟和尼古丁成瘾产品市场分析中使用的各种策略矩阵来促进他们的决策。

公司简介
- GlaxoSmithKline plc（GSK）
- Pfizer Inc.
- Johnson &Johnson
- Novartis International AG
- Imperial Brands plc
- British American Tobacco plc（BAT）
- Cipla Inc.
- McNeil AB
- NJOY, Inc.
- Dr. Reddy's Laboratories Ltd.
- Perrigo Company plc
- Fertin Pharma
- Philip Morris International Inc.
- Alkalon A/S
- Japan Tobacco Inc.
- Nicotek, LLC
- 22nd Century Group Inc.

第10章分析师建议

上升和下降
综合机会图

第十一章参考文献与调查方法

参考
调查方法

简介目录

Product Code: CMI134

The Global Smoking Cessation and Nicotine De-addiction Products Market is estimated to be valued at USD 16.55 Bn in 2024 and is expected to reach USD 50.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 17.1% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 16.55 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	17.10%	2031 Value Projection:	US$ 50.10 Bn

Figure. Smoking Cessation and Nicotine De-addiction Products Market Share (%), By Region 2024

Smoking Cessation and Nicotine De-addiction Products Market - IMG1

The global market for smoking cessation and nicotine de-addiction products is growing significantly owing to the rising global population of smokers and increasing awareness about health hazards of smoking. Smoking has become a worldwide public health issue and the World Health Organization (WHO) recommends various measures to help people quit tobacco consumption. Nicotine replacement therapies and other smoking cessation aids are proving effective in assisting smokers to break the habit. Several awareness campaigns by governments and NGOs have boosted the demand for nicotine gums, patches, lozenges and prescription medications for quitting smoking. Advancements in product formulations and newer technologies are expanding the choices available to smokers who want to quit. However, high prices of certain de-addiction products and persistence of tobacco addiction pose challenges to the industry.

Market Dynamics:

The global smoking cessation and nicotine de-addiction products market growth is driven by the increasing prevalence of smoking-related diseases, growing health consciousness among consumers, and various initiatives by public organizations to curb tobacco use. However, high costs of certain smoking cessation therapies, along with strong tobacco industry lobbying against product regulations, are restraining the market growth. The widespread adoption of digital solutions for smoking cessation therapies is opening new opportunities. Various mobile apps and online programs are being developed to improve the effectiveness of nicotine replacement therapies and behavioral support for consumers. Innovation in alternate delivery forms of nicotine is another key trend gaining traction.

Key Features of the Study:

This report provides in-depth analysis of the global smoking cessation and nicotine de-addiction products market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global smoking cessation and nicotine de-addiction products market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GlaxoSmithKline, Pfizer, Johnson & Johnson, and Dr. Reddy's Laboratories
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global smoking cessation and nicotine de-addiction products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global smoking cessation and nicotine de-addiction products market.

Detailed Segmentation-

By Route of Administration
- Oral
- Transdermal
- Nasal
- Sublingual
- Oral
By Product
- Nicotine Replacement Therapy
- Nicotine Spray
- Nicotine Inhalers
- Nicotine Gum
- Nicotine Transdermal Patches
- Nicotine Sublingual Tablets
- Nicotine Lozenges
- Drug Therapy
- Varenicline
- Zyban
- Nicorette Buccal
- E-cigarettes/E-liquid
By Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- GlaxoSmithKline plc (GSK)
- Pfizer Inc.
- Johnson & Johnson
- Novartis International AG
- Imperial Brands plc
- British American Tobacco plc (BAT)
- Cipla Inc.
- McNeil AB
- NJOY, Inc.
- Reddy's Laboratories Ltd.
- Perrigo Company plc
- Fertin Pharma
- Philip Morris International Inc.
- Alkalon A/S
- Japan Tobacco Inc.
- Nicotek, LLC
- 22nd Century Group Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Route of Administration
- Market Snapshot, By Product
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Smoking Cessation and Nicotine De-addiction Products Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Smoking Cessation and Nicotine De-addiction Products Market, By Route of Administration, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Transdermal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nasal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Sublingual
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Smoking Cessation and Nicotine De-addiction Products Market, By Product, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Nicotine Replacement Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nicotine Spray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nicotine Inhalers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nicotine Gum
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nicotine Transdermal Patches
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nicotine Sublingual Tablets
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nicotine Lozenges
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Drug Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Varenicline
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Zyban
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nicorette Buccal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
E-cigarettes/E-liquid
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Smoking Cessation and Nicotine De-addiction Products Market, By Distribution Channel, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospital Pharmacy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Smoking Cessation and Nicotine De-addiction Products Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- GlaxoSmithKline plc (GSK)
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer Inc.
- Johnson & Johnson
- Novartis International AG
- Imperial Brands plc
- British American Tobacco plc (BAT)
- Cipla Inc.
- McNeil AB
- NJOY, Inc.
- Dr. Reddy's Laboratories Ltd.
- Perrigo Company plc
- Fertin Pharma
- Philip Morris International Inc.
- Alkalon A/S
- Japan Tobacco Inc.
- Nicotek, LLC
- 22nd Century Group Inc.

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

戒烟和尼古丁成瘾预防产品市场：按给药途径、按产品、按分销管道、按地区